Back to PFE Stock Lookup

PFE Related FDA

May 20, 2013 05:05 PM Pfizer (PFE) Discontinues Phase 3 Study of Inotuzumab Ozogamicin

May 16, 2013 08:05 AM Zoetis (ZTS) Reveise FDA Approval of APOQUEL

May 10, 2013 07:32 AM Pfizer (PFE) Considering Options for Remoxy (DRRX)

May 10, 2013 07:25 AM Pain Therapeutics (PTIE) Falls After Pfizer (PFE) Letter

Apr 30, 2013 07:10 AM Pfizer, Inc. (PFE) Misses Q1 EPS by 1c; Updates FY13 Outlook

Apr 29, 2013 07:32 AM Merck (MRK), Pfizer (PFE) Enter Ertugliflozin Development Agreement

Apr 25, 2013 05:58 PM EU Rejection of XELJANZ Will Cost Pfizer (PFE) Millions

Apr 25, 2013 08:00 AM Pfizer (PFE) Reports Celebrex Phase 4 Met Primary Endpoint

Apr 12, 2013 04:15 PM SAC Capital Sued by Wyeth Investors Over Alleged Insider Trading

Apr 10, 2013 11:17 AM Pfizer's (PFE) Palbociclib Has $5 Billion Potential

Apr 10, 2013 08:03 AM Pfizer's (PFE) Palbociclib Receives Breakthrough Therapy Designation from FDA

Apr 3, 2013 04:54 PM Auxilium (AUXL) Enters Transition Services Agreement w/ Pfizer (PFE) for XIAPEX

Mar 25, 2013 07:11 AM Pfizer Inc. (PFE) XELJANZ Receives Approval in Japan

Mar 18, 2013 02:17 PM Pfizer (PFE), Protalix (PTX) UPLYSO Receives Approval in Brazil

Mar 12, 2013 03:22 PM Pfizer's (PFE) Zithromax Gets Stronger Warning Label

Mar 8, 2013 11:58 AM Pfizer (PFE) stops developing hep-C drug on strategic review - DJN

Mar 5, 2013 11:50 AM Pfizer (PFE) Ticks Higher on Extension of Celebrex Exclusivity; Unleases Lawsuits (TEVA) (MYL)

Mar 4, 2013 04:05 PM Pfizer (PFE) Prevnar HIV Study Data Released

Feb 21, 2013 08:01 AM Pfizer's (PFE) Lyrica Met Primary Endpoint in Phase 3

Jan 25, 2013 04:23 PM Pfizer (PFE) Receives FDA Approval for Expanded Prevnar 13 Indication

Jan 14, 2013 10:28 AM Pfizer (PFE) Ticks Higher as New ADHD Treatment Comes to U.S. Market

Jan 8, 2013 07:19 AM Pfizer (PFE) Receives EC Approval for Expanded Prevenar 13 Indication

Jan 3, 2013 07:35 AM Repligen (RGEN) Enters Exclusive Licensing Agreement w/ Pfizer (PFE) for SMA Program

Jan 2, 2013 08:03 AM ELIQUIS Receives FDA Approval in Reducing Certain Risks in Nonvalvular Atrial Fibrillation

Dec 28, 2012 04:14 PM Pfizer (PFE) and Bristol-Meyers (BMY) win FDA approval for Eliquis

Dec 26, 2012 07:30 AM Bristol-Myers (BMY), Pfizer (PFE) Receive Approval for ELIQUIS in Japan

Dec 21, 2012 07:37 AM Halozyme (HALO) Enters Collaboration with Pfizer (PFE) Using Enhanze Tecnology

Dec 13, 2012 05:12 PM FDA Accepts Pfizer (PFE) Ligand (LGND) NDA For Bazedoxifene/Conjugated Estrogens

Dec 11, 2012 05:44 PM Lpath (LPTN) Enters Option w/ Pfizer (PFE) Over iSONEP; Has Value Up to $497.5M + Royalties

Dec 6, 2012 07:49 AM Protalix (PLX) Enters ELELYSO Development Agreement w/ Pfizer (PFE)

Nov 26, 2012 09:52 AM Aceto (ACET) Unit to Launch Generic Version of Pfizer's (PFE) Cleocin Pediatric

Nov 20, 2012 01:55 PM Bristol-Myers (BMY), Pfizer (PFE) Receive EC Approval for ELIQUIS

Nov 19, 2012 08:01 AM Pfizer (PFE) Repors Statistically Significant Data from Pregabalin CR Phase 3

Nov 16, 2012 08:01 AM Pfizer's (PFE) Pregabalin Missed Primary Endpoint in Phase 3

Nov 16, 2012 08:00 AM Pfizer's (PFE) Prevenar 13 Get Positive Opinion from CHMP for Expanded Indication

Nov 14, 2012 02:33 PM Sizing Incyte (INCY) vs. Pfizer (PFE) in Treatment for Rheumatoid Arthritis

Nov 12, 2012 08:43 AM Watson Pharma (WPI) Unit Receives FDA Approval for Generic Revatio ANDA (PFE)

Nov 7, 2012 07:28 AM Auxilium (AUXL), Pfizer (PFE) to End XIAPEX Collaboration Following EU Commercialization

Nov 6, 2012 04:57 PM Pfizer (PFE) Receives FDA Approval for XELJANZ as RA Treatment

Nov 1, 2012 11:04 AM Pfizer (PFE),Protalix (PLX) Report Taliglucerase Alfa Denied Marketing Approval by EC

Oct 24, 2012 11:02 AM Pfizer (PFE) Receives Conditional Approval for XALKORI Marketing in EU

Oct 17, 2012 06:14 AM Pfizer's (PFE) INLYTA Phase 3 Misses Primary Endpoint in Advanced RCC

Oct 16, 2012 08:06 AM Pfizer (PFE) Says CHANTIX/CHAMPIX Met Endpoints as MDD Treatment

Oct 11, 2012 08:59 AM Pfizer (PFE) Says ALO-02 Adverse Event Expectations Met in Phase 3

Oct 4, 2012 08:21 AM Pfizer (PFE) Ticks Higher; Prevenar 13 Met Primary Objective

Oct 4, 2012 08:16 AM Pfizer (PFE) Announces Top-Line Results Of Prevenar 13 Phase 3 Trial

Oct 2, 2012 07:02 AM Antares Pharma (ATRS) Says Pfizer (PFE) Hit Development Milestone, Payment Triggered

Oct 1, 2012 02:04 PM FDA Grants Pfizer's (PFE) Crizotinib Orphan Drug Designation - Bloomberg

Sep 27, 2012 06:33 AM Protalix Bio (PLX) Gets Elelyso Marketing Authorization in Israel

Sep 26, 2012 05:03 PM Bristol-Myers (BMY), Pfizer (PFE) Report FDA Acknowledgment of ELIQUIS NDA Resubmission

Back to PFE Stock Lookup